Haruko Takizawa1, Yasunobu Sekiguchi1, Mutsumi Wakabayashi1, Hiroko Iizuka1, Keiji Sugimoto1, Sakura Sakajiri1, Hiroshi Izumi2, Shigeki Tomita2, Mitsuo Okubo3, Tomohiro Sawada4, Norio Komatsu5, Masaaki Noguchi1 (1.Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan, 2.Department of Pathology, Juntendo University Urayasu Hospital, 3.Department of Blood Transfusion, Juntendo University Urayasu Hospital, 4.Department of Clinical Laboratory, Juntendo University Urayasu Hospital, 5.Department of Hematology, Juntendo University Juntendo Hospital)
Session information
Poster Session
Fri.Oct,11
Poster Session 1-17 Indolent Lymphoma: Treatment (1)
Fri. Oct 11, 2019 5:40 PM - 6:20 PM Poster (Tokyo International Forum, B2F Hall E)
Chair: Masaaki Noguchi (Hematol, Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan)
Takayoshi Miyazono1, Tomohisa Tabuchi1, Jun Odawara1, Nobuaki Nakano1, Ayumu Kubota1, Masahito Tokunaga1, Yukie Tashiro2, Yoshikiyo Ito1, Atae Utsunomiya1 (1.Department of Hematology, Imamura General Hospital, Kagoshima, Japan, 2.Department of Pathology, Imamura General Hospital, Kagoshima, Japan)
Takeharu Kotani, Noriharu Nakagawa, Chizuru Saito, Chiharu Sugimori, Masaki Yamaguchi (Ishikawa Prefectural Central Hospital)
Yasunobu Sekiguchi1, Mutsumi Wakabayashi1, Haruko Takizawa1, Hiroko Iizuka1, Sakura Sakajiri1, Keiji Sugimoto1, Hiroshi Izumi2, Shigeki Tomita2, Mitsuo Okubo3, Tomohiro Sawada4, Norio Komatsu5, Masaaki Noguchi1 (1.Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan, 2.Department of Pathology, Juntendo University Urayasu Hospital, 3.Department of Blood Transfusion, Juntendo University Urayasu Hospital, 4.Department of Clinical Laboratory, Juntendo University Urayasu Hospital, 5.Department of Hematology, Juntendo University Juntendo Hospital)
[PS1-17-5] Safe and successful treatment with B-R therapy for relapsed and refractory FL on dialysis
Kensuke Narukawa1, Akihiko Nishijima1, Yuki Osada1, Atsushi Hamamura1, Hina Takano2, Gaku Oshikawa1 (1.Department of Hematology, Japanese Red Cross Musashino Hospital, Tokyo, Japan, 2.Department of Transfusion, Japanese Red Cross Musashino Hospital, Tokyo, Japan)
Daisuke Nagase, Haruka Fujino, Naoki Onda, Hirofumi Irita, Ai Hirota, Yurika Mitsui, Motohiro Kato, Masanori Umeda, Yasunobu Kuraishi, Kazuhiko Natori (Division of Hematology and Oncology, Department of Medicine, Toho University)
Katsuma Tani1, Daisuke Ennishi2, Hiromi Otuki4, Yuuki Yokokawa4, Miyu Kanbara4, Natsuko Yabuta4, Machiko Matsui4, Mako Satou4, Tomomi Murakami4, Kumiko Saimyouji4, Hitomi Goujyou4, Motoki Mochii3, Hiroki Hujitaka3, Kazuya Ishii3, Naho Nomura1, Taiga Kuroi1, Sachiyo Okamoto1, Taro Masunari1, Nobuo Sezaki1, Toru Kiguchi1 (1.Chugoku Central Hospital, Hiroshima, Japan, 2.Hematology, Oncology and Respiratory Medicine, Okayama University Hospital, Okayama, Japan, 3.Chugoku Central Hospital, Pharmaceutical department, Hiroshima, Japan, 4.Chugoku Central Hospital, Nursing department, Hiroshima, Japan)
Reiki Ogasawara, Shinpei Harada, Koh Izumiyama, Akio Mori, Makoto Saito, Masanori Tanaka, Masanobu Morioka, Takeshi Kondo (Blood Disorders Center, Aiiku Hospital, Sapporo, Japan)